Pediapharm Inc. (CVE:PDP – Get Free Report) rose 1.7% during mid-day trading on Thursday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares were traded during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12. The firm has a market capitalization of C$66.36 million and a P/E ratio of -4.11. The business has a fifty day moving average of C$0.30 and a 200-day moving average of C$0.30.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Further Reading
- Five stocks we like better than Pediapharm
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Investing In Automotive Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is the S&P/TSX Index?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.